These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11201893)

  • 21. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 22. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single dose ROM therapy in Goa.
    Shukla P; Miranda MS; Prabhudesai R; Rege VL
    Indian J Lepr; 2002; 74(2):169-72. PubMed ID: 12708738
    [No Abstract]   [Full Text] [Related]  

  • 24. Single-dose treatment for single lesion leprosy; histopathological observations.
    Shinde A; Khopkar U; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):328-30. PubMed ID: 11221099
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparative trial of single dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions.
    2-3 Lesion Multicentre Trial Group
    Indian J Lepr; 2001; 73(2):131-43. PubMed ID: 11579649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions.
    Deshmukh AR; Dhurat RS; Jerajani HR
    Indian J Lepr; 2003; 75(3):209-17. PubMed ID: 15267190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
    Kumar A; Girdhar A; Girdhar BK
    Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
    Lockwood DN
    Lepr Rev; 1997 Dec; 68(4):299-300. PubMed ID: 9503865
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparative evaluation of skin and nerve histopathology in single skin lesion leprosy.
    Reddy RR; Singh G; Sacchidanand S; Okade R; Shivakumar V; Uday A; Haneef NS
    Indian J Dermatol Venereol Leprol; 2005; 71(6):401-5. PubMed ID: 16394481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term follow-up of ofloxacin-combined therapy for leprosy patients].
    Ozaki M; Ishikawa M
    Nihon Hansenbyo Gakkai Zasshi; 2007 Sep; 76(3):207-18. PubMed ID: 17877033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy.
    Ji B; Grosset J
    Lepr Rev; 2000 Dec; 71 Suppl():S81-7. PubMed ID: 11201894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens.
    Emmanuel M; Gupte MD
    Indian J Lepr; 2005; 77(1):19-25. PubMed ID: 16173416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
    Pattyn S; Grillone S
    Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
    Ji B
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368
    [No Abstract]   [Full Text] [Related]  

  • 36. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S; Reddy R
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract]   [Full Text] [Related]  

  • 37. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.
    Ji B; Sow S; Perani E; Lienhardt C; Diderot V; Grosset J
    Antimicrob Agents Chemother; 1998 May; 42(5):1115-20. PubMed ID: 9593137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [High prevalence of leprosy in the Federated States of Micronesia and special project for the elimination].
    Matsuoka M
    Nihon Hansenbyo Gakkai Zasshi; 1997 Nov; 66(3):199-205. PubMed ID: 9513345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study.
    Martelli CM; Stefani MM; Gomes MK; Rebello PF; Peninni S; Narahashi K; Maroclo AL; Costa MB; Silva SA; Sacchetim SC; Nery JA; Salles AM; Gillis TP; Krahenbuhl JL; Andrade AL
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):247-57. PubMed ID: 11221086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
    Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
    Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.